Involvement of an IgE/Mast cell/B cell amplification loop in abdominal aortic aneurysm progression

PLoS One. 2023 Dec 6;18(12):e0295408. doi: 10.1371/journal.pone.0295408. eCollection 2023.

Abstract

Aims: IgE type immunoglobulins and their specific effector cells, mast cells (MCs), are associated with abdominal aortic aneurysm (AAA) progression. In parallel, immunoglobulin-producing B cells, organised in tertiary lymphoid organs (TLOs) within the aortic wall, have also been linked to aneurysmal progression. We aimed at investigating the potential role and mechanism linking local MCs, TLO B cells, and IgE production in aneurysmal progression.

Methods and results: Through histological assays conducted on human surgical samples from AAA patients, we uncovered that activated MCs were enriched at sites of unhealed haematomas, due to subclinical aortic wall fissuring, in close proximity to adventitial IgE+ TLO B cells. Remarkably, in vitro the IgEs deriving from these samples enhanced MC production of IL-4, a cytokine which favors IgE class-switching and production by B cells. Finally, the role of MCs in aneurysmal progression was further analysed in vivo in ApoE-/- mice subjected to angiotensin II infusion aneurysm model, through MC-specific depletion after the establishment of dissecting aneurysms. MC-specific depletion improved intramural haematoma healing and reduced aneurysmal progression.

Conclusions: Our data suggest that MC located close to aortic wall fissures are activated by adventitial TLO B cell-produced IgEs and participate to their own activation by providing support for further IgE synthesis through IL-4 production. By preventing prompt repair of aortic subclinical fissures, such a runaway MC activation loop could precipitate aneurysmal progression, suggesting that MC-targeting treatments may represent an interesting adjunctive therapy for reducing AAA progression.

MeSH terms

  • Angiotensin II / metabolism
  • Animals
  • Aorta, Abdominal / pathology
  • Aortic Aneurysm, Abdominal* / pathology
  • Disease Models, Animal
  • Humans
  • Immunoglobulin E / metabolism
  • Interleukin-4 / metabolism
  • Mast Cells* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout, ApoE

Substances

  • Interleukin-4
  • Immunoglobulin E
  • Angiotensin II

Grants and funding

This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM), the Université Paris Cité, and an Emergence grant from the Département Hospitalo-Universitaire ‘Fibrosis, Inflammation, REmodeling in cardiovascular, respiratory and renal diseases’ (DHU FIRE, Paris, France). AL was supported by the Domaine d’Intérêt Majeur ‘Maladies Cardiovasculaires, Obésité, Rein, Diabète’ (CORDDIM) from the Region Ile de France, and the Groupe de Réflexion sur la Recherche Cardiovasculaire (GRRC)/Fédération Française de Cardiologie (FFC, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Powered by.